From GlobeNewswire: 2025-06-21 08:00:00

The Long Read Sequencing Market was valued at USD 595.91 million in 2023, projected to reach USD 6,977.05 million by 2032, with a CAGR of 31.53%. The U.S. market alone is expected to grow from USD 220.26 million in 2023 to USD 2,541.49 million by 2032, driven by advances in genomics research and precision medicine.

Consumables dominate the market with a 62.46% share in 2024, driving recurring revenue through repeated purchases. Nanopore sequencing leads with a 62.25% market share due to real-time analysis capabilities. Sequencing holds the largest market share at 60.18%, emphasizing the importance of accurate, high-throughput workflows.

North America leads the Long Read Sequencing Market, holding a 51.11% market share in 2024. Asia Pacific is projected to witness the fastest growth with a 32.34% CAGR, driven by increasing investments in healthcare and demand for personalized therapies. Key players continue to invest in genomics research and precision medicine, propelling market growth globally.



Read more at GlobeNewswire: Long Read Sequencing Market Projected to Reach USD 6.98